Tidmarsh George F's Form 4 filing
Revelation Biosciences, Inc. (REVB) · filed Apr 19, 2023
- Accession no.
- 0001209191-23-024898
- Filed
- Apr 19, 2023
- Trade date
- Apr 17-18, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $59.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tidmarsh George FCIK 0001287235 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 17, 2023 | Common Stock | PPurchaseAcquired | +26,500 | $1.16 | +$30,740 | 39,848 | Direct | |
| Apr 18, 2023 | Common Stock | PPurchaseAcquired | +25,000 | $1.16 | +$29,000 | 64,848 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.